Literature DB >> 20698110

Serum immunoglobulins in non-Hodgkin's lymphoma patients.

Ana Planinc-Peraica1, Slobodanka Ostojić Kolonić, Delfa Radić-Kristo, Mara Dominis, Branimir Jaksić.   

Abstract

Serum proteins and immunoglobulin (Ig) findings in 119 non-Hodgkin's lymphoma (NHL) patients were analysed. Out of them 96 (81%) patients had B non-Hodgkin lymphoma (B-NHL), and 23 (19%) T-NHL. Indolent type of NHL was more frequent (77 patients, 65%), then aggressive type of NHL (42 patients, 35%). Most patients had normal serum protein concentration, the increased protein concentration was seen in 17% of patients while decreased concentration was noticed in 7% of patients. Hypoalbuminaemia was more frequent (43%) then hyperalbuminaemia (1%). In contrast to albumin, low levels of other protein fractions (alpha1-, alpha2-, and beta-globulin) were rather rare (0.6%, 4%, and 3% of patients, respectively) and high levels were frequent (23%, 37%, and 8%, respectively). Polyclonal hyperimmunoglobulinaemia was more frequent finding than hypoimmunoglobulinaemia. In 29% patients higher IgG level and in 25% patients higher IgA level were found. IgM hypoimmunoglobulinaemia (22%) was more frequent than IgG (11%) and IgA (8%) hypoimmunoglobulinaemia. M-spike in serum protein electrophoresis was found in 11 (7%) patients. The statistically significant association was not found between serum Ig concentration and lymphoma malignancy grade as well as between serum Ig concentration and immunologic origin of lymphoma. T-NHL patients have more often IgA concentration level above or under normal values than B-NHL patients (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698110

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  5 in total

1.  Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited.

Authors:  Vincent Allain; Virginie Grandin; Véronique Meignin; Rémi Bertinchamp; David Boutboul; Claire Fieschi; Lionel Galicier; Laurence Gérard; Marion Malphettes; Jacinta Bustamante; Mathieu Fusaro; Nathalie Lambert; Jérémie Rosain; Christelle Lenoir; Sven Kracker; Frédéric Rieux-Laucat; Sylvain Latour; Jean-Pierre de Villartay; Capucine Picard; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2022-09-26       Impact factor: 8.542

2.  Prevalence of Occult Hepatitis C Virus Infection in Egyptian Patients with Lymphoma: A New Vision.

Authors:  Kholoud A Elkashef; Wafaa A Emam; Noha M Mesbah; Dina M Abo-Elmatty; Asmaa R Abdel-Hamed
Journal:  Diagnostics (Basel)       Date:  2022-04-17

3.  Characteristics of Potential Protein Biomarkers Extracted with 10% TCA from Blood Serum of Non-Hodgkin's Lymphoma and Multiple Myeloma Patients.

Authors:  Severyn Myronovskij; Olga Shalay; Veronika Spivak; Rostyslav Stoika; Yuriy Kit
Journal:  Int J Mol Cell Med       Date:  2017-11-11

4.  The immunosignature of canine lymphoma: characterization and diagnostic application.

Authors:  Stephen Albert Johnston; Douglas H Thamm; Joseph Barten Legutki
Journal:  BMC Cancer       Date:  2014-09-08       Impact factor: 4.430

5.  Clinical association of baseline levels of conjugated dienes in low-density lipoprotein and nitric oxide with aggressive B-cell non-Hodgkin lymphoma and their relationship with immunoglobulins and Th1-to-Th2 ratio.

Authors:  Mustapha Haddouche; Warda Meziane; Zeyneb Hadjidj; Naima Mesli; Mourad Aribi
Journal:  J Blood Med       Date:  2016-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.